Biogen Inc. (Nasdaq: BIIB) and Vanqua Bio today announced a license agreement granting Biogen exclusive worldwide rights to Vanqua’s preclinical, oral C5aR1 antagonist. This agreement strengthens ...

This combined approach has been a boon for research on natural killer (NK) cells (white blood cells that destroy diseased cells), says Eric Vivier, an immunologist at the Centre for Immunology of ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

Study reveals how lipids guide proteins inside immune cells, enabling the precise release of cytotoxic granules used to kill ...

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our ...

The same cell product could potentially be used to treat multiple solid tumors like ovarian, pancreatic and lung cancers.

E. John Wherry, director of Penn's Colton Center for Autoimmunity, spoke with the Inquirer about the future of immunology research at Penn and the new $376 million research facility.

Immunology's transformative impact on global health, from Nobel Prizes to COVID-19 vaccines, underscores its critical role in ...

Researchers have revealed a novel mechanism by which the chromatin remodeler brahma-related gene 1 (Brg1) regulates Group 2 ...

Home > Pressemitteilung: How immune cells deliver their deadly ...

MIT and Harvard reserchers have developed immune-evading CAR-NK cells that eliminate cancer in mice while avoiding cytokine ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...